Research programme: respiratory disorders therapeutics - InterMune
Latest Information Update: 13 Apr 2010
At a glance
- Originator InterMune
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory tract disorders
Most Recent Events
- 13 Apr 2010 Discontinued - Preclinical for Respiratory tract disorders in Italy (unspecified route)
- 28 Jun 2007 Preclinical trials in Respiratory tract disorders in Italy (unspecified route)